Sapiens International NV (SPNS) - Stock & Dividends

Exchange: USA Stocks • Country: Israel • Currency: USD • Type: Common Stock • ISIN: KYG7T16G1039

Insurance, Software, Solutions

Sapiens International Corporation N.V. is a leading provider of innovative software solutions specifically designed for the insurance industry, catering to clients across the globe, including North America, the UK, Europe, the Middle East, Africa, and the Asia Pacific.

The company's comprehensive portfolio of solutions covers a broad range of areas, including property and casualty commercial and personal lines, life and pensions, and reinsurance. This enables insurers to streamline their operations, enhance customer engagement, and drive business growth.

One of its flagship products is IDITSuite, an AI-powered, end-to-end insurance software that leverages artificial intelligence to automate and optimize insurance processes. Additionally, Sapiens offers DigitalSuite, a cloud-native digital engagement platform that enables insurers to create personalized, omnichannel experiences for their customers.

For insurers looking to accelerate their digital transformation, Sapiens provides IDITGo, a pre-configured, data-enriched insurance launch and accelerator platform solution. The company also offers consultancy services for property and casualty commercial lines, as well as Tia Enterprise solution for customer engagement.

In the life insurance space, Sapiens offers CoreSuite, an end-to-end cloud and digital policy administration system (PAS) that supports individual and group products across life, health, wealth, and pensions. The company's CustomerConnect platform enables insurers to engage with their customers through a dynamic self-service and persona-based portal.

For agents and brokers, Sapiens provides AgentConnect, a portal designed to enhance sales enablement, customer retention, and customer value. Furthermore, the company's ReinsuranceMaster software automates the reinsurance process, giving insurers full financial control and flexibility over their entire reinsurance operations.

Founded in 1982, Sapiens International Corporation N.V. is headquartered in Holon, Israel, and has established itself as a trusted partner for insurers seeking to modernize their operations and stay ahead in a rapidly changing industry. You can learn more about the company and its innovative solutions at https://www.sapiens.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Sapiens International NV (SPNS) - Stock & Dividends

SPNS Stock Overview

Market Cap in USD 1,942m
Sector Technology
Industry Software - Application
GiC SubIndustry Application Software
TER 0.00%
IPO / Inception 1992-05-29

SPNS Stock Ratings

Growth 5y 4.89
Fundamental 78.4
Dividend 4.69
Rel. Performance vs Sector 0.41
Analysts 3.33/5
Fair Price Momentum 32.44 USD
Fair Price DCF 29.42 USD

SPNS Dividends

Yield 12m 1.59%
Yield on Cost 5y 3.76%
Dividends CAGR 5y 0.71%
Payout Consistency 76.4%

SPNS Growth Ratios

Growth 12m 39.30%
Growth Correlation 12m 46%
Growth Correlation 3m 52%
CAGR 5y 18.75%
CAGR/Mean DD 5y 0.95
Sharpe Ratio 12m 1.21
Alpha vs SP500 12m 5.77
Beta vs SP500 5y weekly 1.25
ValueRay RSI 58.61
Volatility GJR Garch 1y 30.74%
Price / SMA 50 6.39%
Price / SMA 200 18.07%
Current Volume 90.5k
Average Volume 20d 152.7k

External Links for SPNS Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of SPNS stocks?
As of May 30, 2024, the stock is trading at USD 33.98 with a total of 90,463 shares traded.
Over the past week, the price has changed by -1.51%, over one month by +7.87%, over three months by +13.06% and over the past year by +39.30%.
What are the forecast for SPNS stock price target?
According to ValueRays Forecast Model, SPNS Sapiens International NV will be worth about 36.3 in May 2025. The stock is currently trading at 33.98. This means that the stock has a potential upside of +6.92%.
Issuer Forecast Upside
Wallstreet Target Price 34.4 1.24
Analysts Target Price 31.4 -7.59
ValueRay Target Price 36.3 6.92